| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $2.5M | -18.4% | +139.4% |
| R&D Expense | $31.7M | -2.9% | +20.7% |
| SG&A Expense | $7.9M | -13.4% | +6.3% |
| Operating Income | -$37.1M | +4.1% | -13.6% |
| Interest Expense | $699K | +1.5% | -27.0% |
| Net Income | -$35.7M | +3.4% | -19.5% |
| EPS (Basic) | -$0.28 |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $169.5M | +0.1% | +27.3% |
| Short-term Investments | $14.9M | -69.3% | -89.2% |
| Current Assets | $188.2M | -14.9% | -31.3% |
| Total Assets | $262.2M | -12.2% | -24.7% |
| Current Liabilities | $29.2M | -6.7% | +1.9% |
| Long-term Debt |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$103.3M | — | — |
| Capital Expenditures | $4.2M | — | — |
| Investing Cash Flow | $94.5M | — | — |
| Financing Cash Flow | -$409K | — | — |
| Free Cash Flow | -$107.6M | — | — |
| +0.0% |
| -12.0% |
| EPS (Diluted) | -$0.28 | +0.0% | -12.0% |
| $32.4M |
| +0.4% |
| +5.8% |
| Total Liabilities | $118.2M | -3.0% | -0.6% |
| Stockholders' Equity | $144.0M | -18.5% | -37.1% |